1. Home
  2. PDEX vs NERV Comparison

PDEX vs NERV Comparison

Compare PDEX & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pro-Dex Inc.

PDEX

Pro-Dex Inc.

HOLD

Current Price

$55.88

Market Cap

197.4M

Sector

Health Care

ML Signal

HOLD

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.51

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDEX
NERV
Founded
1978
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.4M
210.1M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
PDEX
NERV
Price
$55.88
$4.51
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$56.00
$10.50
AVG Volume (30 Days)
81.6K
379.3K
Earning Date
05-01-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
345.00
N/A
EPS
3.27
N/A
Revenue
$66,593,000.00
$41,175,600.00
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.72
N/A
Revenue Growth
23.68
N/A
52 Week Low
$23.52
$1.76
52 Week High
$68.99
$12.46

Technical Indicators

Market Signals
Indicator
PDEX
NERV
Relative Strength Index (RSI) 40.74 47.36
Support Level $55.29 $3.77
Resistance Level $61.62 $4.59
Average True Range (ATR) 3.53 0.39
MACD -0.67 -0.01
Stochastic Oscillator 14.67 34.16

Price Performance

Historical Comparison
PDEX
NERV

About PDEX Pro-Dex Inc.

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: